{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:58:49Z","timestamp":1781675929455,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82205064"],"award-info":[{"award-number":["82205064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2026JJ60631"],"award-info":[{"award-number":["2026JJ60631"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Project of the Health Commission of Hunan Province","award":["20254247"],"award-info":[{"award-number":["20254247"]}]},{"name":"Hunan Provincial Science and Technology Innovation Program","award":["2023RC3215"],"award-info":[{"award-number":["2023RC3215"]}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2024JJ5236"],"award-info":[{"award-number":["2024JJ5236"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Furong Laboratory Science and Technology Research Project","award":["2023SK2113-2"],"award-info":[{"award-number":["2023SK2113-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05970-1","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:46:23Z","timestamp":1781675183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycogen Synthase Kinase-3\u03b2 Inhibition Ameliorates Synaptic and Mitochondrial Dysfunction in a Sporadic Alzheimer\u2019s Disease\u2013Like Model"],"prefix":"10.1007","volume":"63","author":[{"given":"Ya-Han","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Wen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"5","key":"5970_CR1","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/mds.26580","volume":"31","author":"M Stamelou","year":"2016","unstructured":"Stamelou M, Sch\u00f6pe J, Wagenpfeil S, Del Ser T, Bang J, Lobach IY, Luong P, Respondek G et al (2016) Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy. Mov Disord 31(5):742\u2013747. https:\/\/doi.org\/10.1002\/mds.26580","journal-title":"Mov Disord"},{"key":"5970_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101580","volume":"51","author":"A Nandi","year":"2022","unstructured":"Nandi A, Counts N, Chen S, Seligman B, Tortorice D, Vigo D, Bloom DE (2022) Global and regional projections of the economic burden of Alzheimer\u2019s disease and related dementias from 2019 to 2050: a value of statistical life approach. eClinicalMedicine 51:101580. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101580","journal-title":"eClinicalMedicine"},{"key":"5970_CR3","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/alz.12901","volume":"19","author":"A Wimo","year":"2023","unstructured":"Wimo A, Seeher K, Cataldi R, Cyhlarova E, Dielemann JL, Frisell O, Guerchet M, J\u00f6nsson L, et al. (2023) The worldwide costs of dementia in 2019. Alzheimers Dement 19:2865\u20132873. https:\/\/doi.org\/10.1002\/alz.12901","journal-title":"Alzheimers Dement"},{"issue":"11","key":"5970_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70774","volume":"21","author":"KA Russ","year":"2025","unstructured":"Russ KA, Lacy K, Dage JL, Foroud T (2025) The National Centralized Repository for Alzheimer\u2019s Disease and Related Dementia\u2019s Biomarker Assay Laboratory: a resource for the Alzheimer\u2019s disease research community. Alzheimers Dement 21(11):e70774. https:\/\/doi.org\/10.1002\/alz.70774","journal-title":"Alzheimers Dement"},{"issue":"4","key":"5970_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2024-102020","volume":"38","author":"N Zhi","year":"2025","unstructured":"Zhi N, Ren R, Qi J, Liu X, Yun Z, Lin S, Hu Y, Li H, et al. (2025) The China Alzheimer Report 2025. Gen Psychiatr 38(4):e102020. https:\/\/doi.org\/10.1136\/gpsych-2024-102020","journal-title":"Gen Psychiatr"},{"issue":"6","key":"5970_CR6","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1002\/alz.13817","volume":"20","author":"J Wang","year":"2024","unstructured":"Wang J, Huang Q, He K, Li J, Guo T, Yang Y, Lin Z, Li S, et al. (2024) Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment. Alzheimers Dement 20(6):3876\u20133888. https:\/\/doi.org\/10.1002\/alz.13817","journal-title":"Alzheimers Dement"},{"issue":"20","key":"5970_CR7","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202502809R","volume":"39","author":"H Yu","year":"2025","unstructured":"Yu H, Chen X, Yang Y, Gu M, Ren K, Wei Z (2025) Decoding glycosylation in neurodegenerative diseases: mechanistic insights and therapeutic opportunities. FASEB J 39(20):e71160. https:\/\/doi.org\/10.1096\/fj.202502809R","journal-title":"FASEB J"},{"key":"5970_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252211955","volume":"25","author":"M Kciuk","year":"2024","unstructured":"Kciuk M, Kruczkowska W, Ga\u0142\u0119ziewska J, Wanke K, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Aleksandrowicz M, Kontek R (2024) Alzheimer\u2019s Disease as Type 3 Diabetes: understanding the link and implications. Int J Mol Sci 25:11955. https:\/\/doi.org\/10.3390\/ijms252211955","journal-title":"Int J Mol Sci"},{"key":"5970_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/jad-2005-7106","volume":"7","author":"SM de la Monte","year":"2005","unstructured":"de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer\u2019s disease. J Alzheimers Dis 7:45\u201361. https:\/\/doi.org\/10.3233\/jad-2005-7106","journal-title":"J Alzheimers Dis"},{"key":"5970_CR10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3233\/JAD-141791","volume":"44","author":"A Claxton","year":"2015","unstructured":"Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, et al. (2015) Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s disease dementia. J Alzheimers Dis 44:897\u2013906. https:\/\/doi.org\/10.3233\/JAD-141791","journal-title":"J Alzheimers Dis"},{"key":"5970_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14818","volume":"30","author":"J Zhao","year":"2024","unstructured":"Zhao J, Wei M, Guo M, Wang M, Niu H, Xu T, Zhou Y (2024) GSK3: a potential target and pending issues for treatment of Alzheimer\u2019s disease. CNS Neurosci Ther 30:e14818. https:\/\/doi.org\/10.1111\/cns.14818","journal-title":"CNS Neurosci Ther"},{"key":"5970_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.34172\/apb.2023.071","volume":"13","author":"SR Shri","year":"2023","unstructured":"Shri SR, Manandhar S, Nayak Y, Pai KSR (2023) Role of GSK-3\u03b2 inhibitors: new promises and opportunities for Alzheimer\u2019s Disease. Adv Pharm Bull 13:688\u2013700. https:\/\/doi.org\/10.34172\/apb.2023.071","journal-title":"Adv Pharm Bull"},{"key":"5970_CR13","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar D, Craft S (2020) Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol 19:758\u2013766. https:\/\/doi.org\/10.1016\/S1474-4422(20)30231-3","journal-title":"Lancet Neurol"},{"key":"5970_CR14","doi-asserted-by":"publisher","unstructured":"Bian Yaqi, Chen Yan,Wang Xiufen, Cui Guozhen, Carolina Oi Lam Ung,...Simon Ming-Yuen Lee (2021) Oxyphylla A ameliorates cognitive deficits and alleviates neuropathology via the Akt-GSK3\u03b2 and Nrf2-Keap1-HO-1 pathways in vitro and in vivo murine models of Alzheimer's disease. J Adv Res 34 1\u201312. https:\/\/doi.org\/10.1016\/j.jare.2021.09.002","DOI":"10.1016\/j.jare.2021.09.002"},{"key":"5970_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00018-023-04874-w","volume":"80","author":"N Moreno","year":"2023","unstructured":"Moreno N, Toni PM, Llorens-Mart\u00edn M (2023) GSK-3beta orchestrates the inhibitory innervation of adult-born dentate granule cells in vivo. Cell Mol Life Sci 80:225. https:\/\/doi.org\/10.1007\/s00018-023-04874-w","journal-title":"Cell Mol Life Sci"},{"key":"5970_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.tem.2008.08.004","volume":"19","author":"HJ Welters","year":"2008","unstructured":"Welters HJ, Kulkarni RN (2008) Wnt signaling: relevance to beta-cell biology and diabetes. Trends Endocrinol Metab 19:349\u2013355. https:\/\/doi.org\/10.1016\/j.tem.2008.08.004","journal-title":"Trends Endocrinol Metab"},{"key":"5970_CR17","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/1873-3468.13502","volume":"593","author":"J Bem","year":"2019","unstructured":"Bem J, Bro\u017cko N, Chakraborty C, Lipiec MA, Kozi\u0144ski K, Nagalski A, Szewczyk \u0141M, Wi\u015bniewska MB (2019) Wnt\/\u03b2\u2010catenin signaling in brain development and mental disorders: keeping TCF7L2 in mind. FEBS Lett 593:1654\u20131674. https:\/\/doi.org\/10.1002\/1873-3468.13502","journal-title":"FEBS Lett"},{"key":"5970_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/B978-0-12-394311-8.00017-0","volume":"116","author":"RK Miller","year":"2013","unstructured":"Miller RK, Hong JY, Mu\u00f1oz WA, McCrea PD (2013) Beta-catenin versus the other catenins: assessing our current view of canonical Wnt signaling. Prog Mol Biol Transl Sci 116:387\u2013407. https:\/\/doi.org\/10.1016\/B978-0-12-394311-8.00017-0","journal-title":"Prog Mol Biol Transl Sci"},{"key":"5970_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuron.2014.08.048","volume":"84","author":"CC Liu","year":"2014","unstructured":"Liu CC, Tsai CW, Deak F, Rogers J, Penuliar M, Sung Y, Maher J, Fu Y et al (2014) Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer\u2019s disease. Neuron 84:63\u201377. https:\/\/doi.org\/10.1016\/j.neuron.2014.08.048","journal-title":"Neuron"},{"key":"5970_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-cellbio-120319-023657","volume":"37","author":"LV Albrecht","year":"2021","unstructured":"Albrecht LV, Tejeda-Mu\u00f1oz N, De Robertis EM (2021) Cell biology of canonical Wnt signaling. Annu Rev Cell Dev Biol 37:369\u2013389. https:\/\/doi.org\/10.1146\/annurev-cellbio-120319-023657","journal-title":"Annu Rev Cell Dev Biol"},{"key":"5970_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09780-z","volume":"10","author":"E Kim","year":"2019","unstructured":"Kim E, Lisby A, Ma C, Lo N, Ehmer U, Hayer KE, Furth EE, Viatour P (2019) Promotion of growth factor signaling as a critical function of \u03b2-catenin during HCC progression. Nat Commun 10:1909. https:\/\/doi.org\/10.1038\/s41467-019-09780-z","journal-title":"Nat Commun"},{"key":"5970_CR22","doi-asserted-by":"publisher","unstructured":"Wang, Q., Huang, X., Su, Y., Yin G., Wang S.,...Yi C. (2022) Activation of Wnt\/beta-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease. Brain 145:4474\u20134488. https:\/\/doi.org\/10.1093\/brain\/awac236","DOI":"10.1093\/brain\/awac236"},{"key":"5970_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-021-02900-x","volume":"11","author":"G Qin","year":"2021","unstructured":"Qin G, Wang Y, Liu Z, Mana L, Huang S, Wang P (2021) Shenzhiling oral solution promotes myelin repair through PI3K\/Akt-mTOR pathway in STZ-induced SAD mice. 3 Biotech 11:361. https:\/\/doi.org\/10.1007\/s13205-021-02900-x","journal-title":"3 Biotech"},{"issue":"30","key":"5970_CR24","doi-asserted-by":"publisher","first-page":"12548","DOI":"10.1073\/pnas.0705281104","volume":"104","author":"F Hamzei-Sichani","year":"2007","unstructured":"Hamzei-Sichani F, Kamasawa N, Janssen WG, Yasumura T, Davidson KG, Janssen WGM, Davidson KGV, Hof PR et al (2007) Gap junctions on hippocampal mossy fiber axons demonstrated by thin-section electron microscopy and freeze fracture replica immunogold labeling. Proc Natl Acad Sci U S A 104(30):12548\u201312553. https:\/\/doi.org\/10.1073\/pnas.0705281104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5970_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.70056","volume":"14","author":"K-X Zhang","year":"2024","unstructured":"Zhang K-X, Sheng N, Ding P-L, Zhang J-W, Xu X-Q, Wang Y-H (2024) Danggui Shaoyao San alleviates early cognitive impairment in Alzheimer\u2019s disease mice through IRS1\/GSK3\u03b2\/Wnt3a\u2010\u03b2\u2010Catenin pathway. Brain and Behavior 14:e70056. https:\/\/doi.org\/10.1002\/brb3.70056","journal-title":"Brain and Behavior"},{"key":"5970_CR26","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2147\/DDDT.S490900","volume":"19","author":"K-X Zhang","year":"2025","unstructured":"Zhang K-X, Zhang J-W, Jiang Y-H, Wang Y-R, Liu Z-L, Ding P-L, Wang X-Y, Cui W-Q et al (2025) Danggui-Shaoyao-San can ameliorate Alzheimer\u2019s disease by inhibiting hippocampal neuron apoptosis: findings from serum pharmacology. Drug Des Devel Ther 19:911\u2013929. https:\/\/doi.org\/10.2147\/DDDT.S490900","journal-title":"Drug Des Devel Ther"},{"key":"5970_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/jnc.14608","volume":"149","author":"P Cisternas","year":"2019","unstructured":"Cisternas P, Zolezzi JM, Martinez M, Torres VI, Wong GW, Inestrosa NC (2019) Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease. J Neurochem 149:54\u201372. https:\/\/doi.org\/10.1111\/jnc.14608","journal-title":"J Neurochem"},{"key":"5970_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05395-3","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Leung J, Yiu WH, Chan LYY, Li B, Leung JCK, Lok SWY, Xue R et al (2022) Tubular \u03b2-catenin alleviates mitochondrial dysfunction and cell death in acute kidney injury. Cell Death Dis 13:1061. https:\/\/doi.org\/10.1038\/s41419-022-05395-3","journal-title":"Cell Death Dis"},{"key":"5970_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.5498\/wjp.v13.i9.630","volume":"13","author":"Z Wang","year":"2023","unstructured":"Wang Z, Li X-N, Yang S-N, Wang Y, Gao K-J, Han B, Ma A-J (2023) Exosomal miR-320e through wnt2targeted inhibition of the Wnt\/\u03b2-catenin pathway allevisate cerebral small vessel disease and cognitive impairment. World J Psychiatry 13:630\u2013644. https:\/\/doi.org\/10.5498\/wjp.v13.i9.630","journal-title":"World J Psychiatry"},{"key":"5970_CR30","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1523\/JNEUROSCI.2944-12.2013","volume":"33","author":"AM Taylor","year":"2013","unstructured":"Taylor AM, Wu J, Tai HC, Schuman EM (2013) Axonal translation of beta-catenin regulates synaptic vesicle dynamics. J Neurosci 33:5584\u20135589. https:\/\/doi.org\/10.1523\/JNEUROSCI.2944-12.2013","journal-title":"J Neurosci"},{"key":"5970_CR31","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1007\/s12035-024-04457-1","volume":"62","author":"M Jie","year":"2025","unstructured":"Jie M, Yanli Z, Chen S, Qiandan Z, Junhong G (2025) Insulin-like growth factor signaling in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurobiol 62:3195\u20133225. https:\/\/doi.org\/10.1007\/s12035-024-04457-1","journal-title":"Mol Neurobiol"},{"key":"5970_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2165\/00023210-200317010-00003","volume":"17","author":"GS Watson","year":"2003","unstructured":"Watson GS, Craft S (2003) The role of insulin resistance in the pathogenesis of Alzheimer\u2019s disease: implications for treatment. CNS Drugs 17:27\u201345. https:\/\/doi.org\/10.2165\/00023210-200317010-00003","journal-title":"CNS Drugs"},{"key":"5970_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04874-w","volume":"9","author":"BJ Neth","year":"2017","unstructured":"Neth BJ, Craft S (2017) Insulin resistance and Alzheimer\u2019s disease: bioenergetic linkages. Front Aging Neurosci 9:345. https:\/\/doi.org\/10.1007\/s00018-023-04874-w","journal-title":"Front Aging Neurosci"},{"key":"5970_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/jad-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR et al (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease - is this type 3 diabetes? J Alzheimers Dis 7:63\u201380. https:\/\/doi.org\/10.3233\/jad-2005-7107","journal-title":"J Alzheimers Dis"},{"key":"5970_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00382-w","volume":"12","author":"I Lepiarz-Raba","year":"2023","unstructured":"Lepiarz-Raba I, Gbadamosi I, Florea R, Paolicelli RC, Jawaid A (2023) Metabolic regulation of microglial phagocytosis: implications for Alzheimer\u2019s disease therapeutics. Transl Neurodegener 12:48. https:\/\/doi.org\/10.1186\/s40035-023-00382-w","journal-title":"Transl Neurodegener"},{"key":"5970_CR36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2212256120","volume":"120","author":"MS Goyal","year":"2023","unstructured":"Goyal MS, Blazey T, Metcalf NV, McAvoy MP, Strain JF, Rahmani M, Durbin TJ, Xiong C et al (2023) Brain aerobic glycolysis and resilience in Alzheimer disease. Proc Natl Acad Sci U S A 120:e2212256120. https:\/\/doi.org\/10.1073\/pnas.2212256120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5970_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12902-022-00968-x","volume":"22","author":"H Wang","year":"2022","unstructured":"Wang H, Huang S, Hu T, Fei S, Zhang H (2022) Circ_0000064 promotes high glucose-induced renal tubular epithelial cells injury to facilitate diabetic nephropathy progression through miR-532-3p\/ROCK1 axis. BMC Endocr Disord 22:67. https:\/\/doi.org\/10.1186\/s12902-022-00968-x","journal-title":"BMC Endocr Disord"},{"key":"5970_CR38","doi-asserted-by":"publisher","unstructured":"Craft, S., Raman, R., Chow, T. W., Rafii, M. S., Sun Chung-Kai,...Aisen, P. S. (2020) Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial. JAMA Neurol 77:1099\u20131109. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1840","DOI":"10.1001\/jamaneurol.2020.1840"},{"key":"5970_CR39","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202256380","volume":"24","author":"BR Desousa","year":"2023","unstructured":"Desousa BR, Kim KK, Jones AE, Ball AB, Hsieh WY, Swain P, Morrow DH, Brownstein AJ et al (2023) Calculation of ATP production rates using the Seahorse XF Analyzer. EMBO Rep 24:e56380. https:\/\/doi.org\/10.15252\/embr.202256380","journal-title":"EMBO Rep"},{"key":"5970_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2024.100629","volume":"65","author":"Z Lan","year":"2024","unstructured":"Lan Z, Lv S, Ge Z, Zhao B, Li L, Li C (2024) Lactic acid regulates lipid droplet aggregation through a microglia-neuron axis in neuroinflammation. J Lipid Res 65:100629. https:\/\/doi.org\/10.1016\/j.jlr.2024.100629","journal-title":"J Lipid Res"},{"key":"5970_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.633495","volume":"13","author":"CC Qi","year":"2021","unstructured":"Qi CC, Chen XX, Gao XR, Xu JX, Liu S, Ge JF (2021) Impaired learning and memory ability induced by a bilaterally hippocampal injection of Streptozotocin in mice: involved with the adaptive changes of synaptic plasticity. Front Aging Neurosci 13:633495. https:\/\/doi.org\/10.3389\/fnagi.2021.633495","journal-title":"Front Aging Neurosci"},{"key":"5970_CR42","doi-asserted-by":"publisher","unstructured":"Zhu L, Hou XJ, Che XH, Zhou TS, Liu XQ, ...Yang JY (2021) Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model. Acta Pharmacol Sin 42:1401\u20131408. https:\/\/doi.org\/10.1038\/s41401-020-00562-8.","DOI":"10.1038\/s41401-020-00562-8"},{"key":"5970_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/physrev.00030.2022","volume":"104","author":"M Perluigi","year":"2024","unstructured":"Perluigi M, Di Domenico F, Butterfield DA (2024) Oxidative damage in neurodegeneration: Roles in the pathogenesis and progression of Alzheimer disease. Physiol Rev 104:103\u2013197. https:\/\/doi.org\/10.1152\/physrev.00030.2022","journal-title":"Physiol Rev"},{"key":"5970_CR44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41419-024-06885-2","volume":"15","author":"M Lin","year":"2024","unstructured":"Lin M, Tu RH, Wu SZ, Zhong Q, Weng K, Li P (2024) Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathway. Cell Death Dis 15:497. https:\/\/doi.org\/10.1038\/s41419-024-06885-2","journal-title":"Cell Death Dis"},{"key":"5970_CR45","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1159\/000485904","volume":"44","author":"P Song","year":"2017","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Jiao X, Cai J, Yu X et al (2017) Paracrine activation of the Wnt\/\u03b2-catenin pathway by bone marrow stem cell attenuates cisplatin-induced kidney injury. Cell Physiol Biochem 44:1980\u20131994. https:\/\/doi.org\/10.1159\/000485904","journal-title":"Cell Physiol Biochem"},{"key":"5970_CR46","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1089\/scd.2016.0072","volume":"25","author":"M Waldman","year":"2016","unstructured":"Waldman M, Bellner L, Vanella L, Schragenheim J, Sodhi K, Singh SP, Lin D, Lakhkar A et al (2016) Epoxyeicosatrienoic acids regulate adipocyte differentiation of mouse 3T3 cells, via PGC-1\u03b1 activation, which is required for HO-1 expression and increased mitochondrial function. Stem Cells Dev 25:1084\u20131094. https:\/\/doi.org\/10.1089\/scd.2016.0072","journal-title":"Stem Cells Dev"},{"key":"5970_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04613-6","volume":"21","author":"H Zhang","year":"2023","unstructured":"Zhang H, Dong X, Ding X, Liu G, Yang F, Song Q, Sun H, Chen G et al (2023) Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt\/\u03b2-catenin signal pathway. J Transl Med 21:900. https:\/\/doi.org\/10.1186\/s12967-023-04613-6","journal-title":"J Transl Med"},{"key":"5970_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105350","volume":"299","author":"R Riquelme","year":"2023","unstructured":"Riquelme R, Li L, Gambrill A, Barria A (2023) ROR2 homodimerization is sufficient to activate a neuronal Wnt\/calcium signaling pathway. J Biol Chem 299:105350. https:\/\/doi.org\/10.1016\/j.jbc.2023.105350","journal-title":"J Biol Chem"},{"key":"5970_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00108","volume":"8","author":"M Gejl","year":"2016","unstructured":"Gejl M, Gjedde A, Egefjord L, M\u00f8ller A, Hansen SB, Vang K, Rodell A, Br\u00e6ndgaard H et al (2016) In Alzheimer\u2019s disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial. Front Aging Neurosci 8:108. https:\/\/doi.org\/10.3389\/fnagi.2016.00108","journal-title":"Front Aging Neurosci"},{"key":"5970_CR50","doi-asserted-by":"publisher","unstructured":"Michael G. Aman, Jill A. Hollway, Jeremy Veenstra-VanderWeele, Benjamin L. Handen, Kevin B. Sanders,... Evdokia A. Anagnostou (2019) Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use.J Child Adolesc Psychopharmacol 28: 266\u2013273. https:\/\/doi.org\/10.1089\/cap.2017.0072","DOI":"10.1089\/cap.2017.0072"},{"key":"5970_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14336\/AD.2016.1010","volume":"8","author":"N Thangthaeng","year":"2017","unstructured":"Thangthaeng N, Rutledge M, Wong JM, Vann PH, Forster MJ, Sumien N (2017) Metformin impairs spatial memory and visual acuity in old male mice. Aging Dis 8:17\u201330. https:\/\/doi.org\/10.14336\/AD.2016.1010","journal-title":"Aging Dis"},{"key":"5970_CR52","doi-asserted-by":"publisher","unstructured":"Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Ch\u00e9telat,G.,...Wiesje M van der Flier (2021) Alzheimer's disease. Lancet 397: 1577\u20131590. https:\/\/doi.org\/10.1111\/ene.13439","DOI":"10.1111\/ene.13439"},{"issue":"8","key":"5970_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17081065","volume":"17","author":"A Di Deo","year":"2025","unstructured":"Di Deo A, Oosterholt S, Horrigan J, Evans S, McMorn A, Della Pasqua O (2025) Population pharmacokinetics of tideglusib in congenital and childhood Myotonic Dystrophy Type 1: Influence of demographic and clinical factors on systemic exposure. Pharmaceutics 17(8):1065. https:\/\/doi.org\/10.3390\/pharmaceutics17081065","journal-title":"Pharmaceutics"},{"issue":"2","key":"5970_CR54","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1074\/jbc.M111.306472","volume":"287","author":"JM Dom\u00ednguez","year":"2012","unstructured":"Dom\u00ednguez JM, Fuertes A, Orozco L, del Monte-Mill\u00e1n M, Delgado E, Medina M (2012) Evidence for irreversible inhibition of glycogen synthase kinase-3\u03b2 by tideglusib. J Biol Chem 287(2):893\u2013904. https:\/\/doi.org\/10.1074\/jbc.M111.306472","journal-title":"J Biol Chem"},{"key":"5970_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09335-x","volume":"3","author":"L Aron","year":"2025","unstructured":"Aron L, Ngian ZK, Qiu C, Choi J, Liang M, Drake DM, Hamplova SE, Lacey EK, et al. (2025) Lithium deficiency and the onset of Alzheimer\u2019s disease. Nature 3:55:43 Z. https:\/\/doi.org\/10.1038\/s41586-025-09335-x","journal-title":"Nature"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05970-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05970-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05970-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:46:26Z","timestamp":1781675186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05970-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5970"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05970-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"697"}}